Clinical Trial: Phase II Clinical Trial to Evaluate the Efficacy and Safety of DW4902

U.S., Jan. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07319520) titled 'Phase II Clinical Trial to Evaluate the Efficacy and Safety of DW4902' on Dec. 22, 2025.

Brief Summary: A Multi-center, Randomized, Double-blind, Placebo-controlled, Therapeutic Exploratory, Phase II Clinical Trial for the Efficacy Investigation and Safety Evaluation of DW4902 in Patients with Uterine Fibroids.

Study Start Date: Oct. 06, 2021

Study Type: INTERVENTIONAL

Condition: Myoma of Uterus

Intervention: DRUG: DW4902 Placebo

Starting from the Baseline Visit (Visit 3), administer orally once daily at a dose of 4 capsules before meals for 12 weeks. (Placebo 4 capsules)

DRUG: DW4902 160mg

Starting from the Baseline Visit (...